Literature DB >> 2881893

Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae.

J L Cowell, J M Zhang, A Urisu, A Suzuki, A C Steven, T Liu, T Y Liu, C R Manclark.   

Abstract

Fimbriae were removed from Bordetella pertussis (serotype 1.3.6) by mechanical shearing and purified by precipitation with ammonium sulfate, pH-dependent precipitation at pH 7.4, followed by two successive extractions of the precipitated fimbriae with 4 M urea. By electron microscopy, the precipitated fimbriae appeared as aggregated bundles of long, relatively straight filaments which were disaggregated to individual flexuous filaments at pH 10.5. These purified fimbriae were identified as serotype 6 agglutinogens, since antibody to the purified fimbriae agglutinated B. pertussis strains serotyped as 1.3.6, 1.2.3.6, or 1.2.3.4.6 but did not agglutinate strains of serotype 1.2.3.4, 1.2.3, or 1.3. In contrast, antibody to serotype 2 fimbriae only agglutinated B. pertussis strains containing serotype 2 agglutinogen. Purified type 6 and 2 fimbriae were found to be weakly cross-reactive by enzyme-linked immunosorbent assay, using polyclonal antibody to each type of fimbria. In an immunoblot assay, polyclonal antibodies to a 22,000-dalton subunit of fimbriae from B. bronchiseptica reacted strongly with the type 2 fimbrial subunit of B. pertussis, but only weakly with the type 6 subunit. When subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the protein subunit of the type 6 fimbriae migrated with a molecular weight of 21,500, whereas the type 2 fimbrial subunit had a molecular weight of 22,000. The two types of subunits had similar amino acid compositions and showed amino-terminal sequence homology in 15 of 21 amino acids. The amino-terminal amino acid sequences of the B. pertussis fimbriae were distinct from those reported for fimbriae from other gram-negative bacteria. Neither the type 6 nor the type 2 fimbriae caused hemagglutination when assayed with several types of erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881893      PMCID: PMC260438          DOI: 10.1128/iai.55.4.916-922.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  X-ray diffraction and electron microscope studies on the structure of bacterial F pili.

Authors:  W Folkhard; K R Leonard; S Malsey; D A Marvin; J Dubochet; A Engel; M Achtman; R Helmuth
Journal:  J Mol Biol       Date:  1979-05-15       Impact factor: 5.469

2.  Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis.

Authors:  L A Ashworth; L I Irons; A B Dowsett
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

3.  Structure of polar pili from Pseudomonas aeruginosa strains K and O.

Authors:  W Folkhard; D A Marvin; T H Watts; W Paranchych
Journal:  J Mol Biol       Date:  1981-06-15       Impact factor: 5.469

4.  Purification and characterization of fimbriae isolated from Bordetella pertussis.

Authors:  J M Zhang; J L Cowell; A C Steven; P H Carter; P P McGrath; C R Manclark
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

5.  Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells.

Authors:  E Tuomanen; A Weiss
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

6.  A reappraisal of serotype factors 4, 5 and 6 of Bordetella pertussis.

Authors:  N W Preston; N Surapatana; E J Carter
Journal:  J Hyg (Lond)       Date:  1982-02

7.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

8.  A gas-liquid solid phase peptide and protein sequenator.

Authors:  R M Hewick; M W Hunkapiller; L E Hood; W J Dreyer
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

9.  Progressive cough associated with lymphocytic leukemoid reaction in an infant.

Authors:  M I Marks; T Stacy; H F Krous
Journal:  J Pediatr       Date:  1980-07       Impact factor: 4.406

10.  Comparative studies of the amino acid and nucleotide sequences of pilin derived from Pseudomonas aeruginosa PAK and PAO.

Authors:  P A Sastry; B B Finlay; B L Pasloske; W Paranchych; J R Pearlstone; L B Smillie
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490

View more
  10 in total

Review 1.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

2.  The major fimbrial subunit of Bordetella pertussis binds to sulfated sugars.

Authors:  C A Geuijen; R J Willems; F R Mooi
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies.

Authors:  Z M Li; M J Brennan; J L David; P H Carter; J L Cowell; C R Manclark
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

Review 4.  Virulence factors of Bordetella pertussis.

Authors:  F R Mooi
Journal:  Antonie Van Leeuwenhoek       Date:  1988       Impact factor: 2.271

5.  Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis.

Authors:  M J Brennan; Z M Li; J L Cowell; M E Bisher; A C Steven; P Novotny; C R Manclark
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

6.  Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis.

Authors:  Z M Li; J L Cowell; M J Brennan; D L Burns; C R Manclark
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

7.  Detection of antibodies to toxin-coregulated pili in sera from cholera patients.

Authors:  Stephen R Attridge; Gun Wallerström; Firdausi Qadri; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Anti-FIM and Anti-FHA Antibodies Inhibit Bordetella pertussis Growth and Reduce Epithelial Cell Inflammation Through Bacterial Aggregation.

Authors:  Issaka Yougbare; Adam McTague; Liwei He; Christopher H Choy; Jin Su; Beata Gajewska; Ali Azizi
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

9.  Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.

Authors:  Yinghua Xu; Yaying Wang; Yajun Tan; Huajie Zhang; Lijie Wu; Lichan Wang; Qiming Hou; Shumin Zhang
Journal:  BMC Microbiol       Date:  2009-12-29       Impact factor: 3.605

10.  Bordetella pertussis isolates in Finland: serotype and fimbrial expression.

Authors:  Eriikka Heikkinen; Dorothy K Xing; Rose-Marie Olander; Jukka Hytönen; Matti K Viljanen; Jussi Mertsola; Qiushui He
Journal:  BMC Microbiol       Date:  2008-09-25       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.